Old Web
English
Sign In
Acemap
>
authorDetail
>
C. Ademokun
C. Ademokun
Fostamatinib
Clinical trial
Thrombocytosis
Internal medicine
Adverse effect
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (1)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Treatment of immune thrombocytopenia (ITP) in the COVID-19 era: Fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor
2021
N. Cooper
A. Charania
A. Hart
C. Ademokun
R. Numerof
Show All
Source
Cite
Save
Citations (0)
1